中医药综合干预技术治疗失眠的临床研究

注册号:

Registration number:

ChiCTR-INR-15007602 

最近更新日期:

Date of Last Refreshed on:

2015-12-18 15:15:47 

注册时间:

Date of Registration:

2015-12-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

中医药综合干预技术治疗失眠的临床研究

Public title:

Clinical Study of TCM Comprehensive Intervention Technology on insomnia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中医药综合干预技术治疗失眠的临床研究

Scientific title:

Clinical Study of TCM Comprehensive Intervention Technology on insomnia

研究课题代号(代码):

Study subject ID:

201507003

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

原嘉民 

研究负责人:

杨志敏 

Applicant:

Jiamin Yuan 

Study leader:

Zhimin Yang 

申请注册联系人电话:

Applicant telephone:

+86 13580355694

研究负责人电话:

Study leader's
telephone:

+86 13822296363

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yjmbeifen@126.com

研究负责人电子邮件:

Study leader's E-mail:

yangyo@vip.tom.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市越秀区大德路111号广东省中医院研修楼19楼06室

研究负责人通讯地址:

广东省广州市越秀区大德路111号广东省中医院研修楼19楼06室

Applicant address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

Study leader's address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

510120

研究负责人邮政编码:

Study leader's postcode:

510120

申请人所在单位:

广东省中医院

Applicant's institution:

Guangdong Province Traditional Chinese Medical Hospital

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

B2015-143-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

The ethics committee of Guangdong Province Traditional Chinese Medical Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广东省中医院

Primary sponsor:

Guangdong Province Traditional Chinese Medical Hospital

研究实施负责(组长)单位地址:

广东省广州市越秀区大德路111号广东省中医院研修楼19楼06室

Primary sponsor's address:

111 Dade Road, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院

具体地址:

广东省广州市越秀区大德路111号广东省中医院研修楼19楼06室

Institution
hospital:

Guangdong Province Traditional Chinese Medical Hospital

Address:

111 Dade Road, Guangzhou, Guangdong, China

国家:

中国

省(直辖市):

四川

市(区县):

成都

Country:

China

Province:

Sichuang

City:

Chengdu

单位(医院):

四川省中西医结合医院

具体地址:

成都市人民南路四段51号

Institution
hospital:

Hospital of integrated traditional Chinese and Western medicine in Sichuan Province

Address:

51 Section 4, Renmin Road South, Chengdu

经费或物资来源:

2015 年度中医药行业科研专项

Source(s) of funding:

2015 annual Chinese medicine industry research projects

研究疾病:

失眠  

Target disease:

insomnia

研究疾病代码:

ICD-10:F51.952

Target disease code:

ICD-10:F51.952

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

通过整群随机对照试验(cluster-randomized trials)方法,观察固定的中医药综合干预技术方案(穴位贴敷、足浴、膏方、睡眠卫生指导)对于失眠人群的干预效果及安全性。  

Objectives of Study:

Observe the clinical effect and safety of TCM comprehensive intervention technique on insomnia by cluster-randomized trials

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)准备怀孕或孕期或哺乳期或需要陪伴小孩一起睡觉的人群。
(2)根据病史与问诊,医生确认由其它疾病引起的继发性失眠。
例如:局部的疼痛、不安腿综合征、睡眠呼吸暂停综合征、急慢性心力衰竭、
慢性阻塞性肺病、急慢性支气管炎
(3)根据患者抑郁自评工具(PHQ-9)诊断为中、重度抑郁患者(总分≥10)
(4)根据广泛性焦虑量表(GAD-7)诊断中、重度焦虑患者(总分≥6)
(5)根据病史与问诊,医生确认为需要按照疾病管理方式管理的患者。

Exclusion criteria:

(1) ready to become pregnant or nursing or need to be accompanied by a child;
(2) according to the history and interrogation, the doctor confirmed other diseases caused by secondary insomnia.
For example: local pain, restless legs syndrome, sleep apnea syndrome, acute and chronic heart failure, Chronic obstructive pulmonary disease, acute and chronic bronchitis;
(3) according to the self rating depression tool (PHQ-9) diagnosed in patients with severe depression (score = 10);
(4) according to the generalized anxiety scale (GAD-7) in the diagnosis of severe anxiety patients (score = 6);
(5) according to the history and the interrogation, the doctor confirmed the need for management of patients according to disease management.

研究实施时间:

Study execute time:

From 2015-05-01 00:00:00 To 2019-05-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2016-02-15 00:00:00 To 2017-02-15 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

91

Group:

test group

Sample size:

干预措施:

穴位贴敷

干预措施代码:

Intervention:

Acupoint application

Intervention code:

组别:

试验组

样本量:

91

Group:

test group

Sample size:

干预措施:

足浴

干预措施代码:

Intervention:

lavipeditum

Intervention code:

组别:

试验组

样本量:

91

Group:

test group

Sample size:

干预措施:

膏方

干预措施代码:

Intervention:

herbal paste

Intervention code:

组别:

对照组

样本量:

91

Group:

control group

Sample size:

干预措施:

安慰剂假穴位穴位贴敷

干预措施代码:

Intervention:

Placebo false Acupoint Application

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

广州市 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院 

单位级别:

三级甲等 

Institution
hospital:

Guangdong Province Traditional Chinese Medical Hospital

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

四川省 

市(区县):

成都市 

Country:

China

Province:

Sichuang

City:

Chengdu

单位(医院):

四川省中西医结合医院 

单位级别:

三级甲等 

Institution
hospital:

Hospital of integrated traditional Chinese and Western medicine in Sichuan Province

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

匹兹堡睡眠质量指数表(PSQI)

指标类型:

主要指标

Outcome:

Pittsburgh sleep quality index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者抑郁自评工具(PHQ-9)

指标类型:

次要指标

Outcome:

Self rating depression

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

广泛性焦虑量表(GAD-7)

指标类型:

次要指标

Outcome:

Generalized anxiety scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失眠症中医生存质量量表(TCMQLI-21)

指标类型:

次要指标

Outcome:

TCM quality of life scale for insomnia

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

便携式睡眠检测仪

指标类型:

次要指标

Outcome:

Portable sleep detector

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规

指标类型:

副作用指标

Outcome:

routine blood

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

尿常规

指标类型:

副作用指标

Outcome:

routine urine

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝功能

指标类型:

副作用指标

Outcome:

liver function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肾功能

指标类型:

副作用指标

Outcome:

renal function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心电图

指标类型:

副作用指标

Outcome:

electrocardiogram

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

副作用指标

Outcome:

blood pressure

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

对单位进行编号,形成抽样框架。 运用简单随机方法对参与单位进行整群随机化,以1:1比例分为两组,运用简单随机方法进行随机,随机数字生成工具采用PASW Statistics 18,随机种子设置为20120801。随机分组规则为,如随机数字的个位为奇数则分配到“1”组,偶数和零则分配到“2”组。分组后,记录各单位的组别及对应的干预方式。 由未知上述整群随机分组结果的工作人员,根据个体纳入排除标准,在各个整群单位中收集病例。

Randomization Procedure (please state who generates the random number sequence and by what method):

Using the simple random method, the unit is randomly divided into two groups. The Statistics 1:1 is divided into 18 groups randomly, and the random number is set to 20120801. The random grouping rule is, if a random number is an odd number, which is assigned to the "1" group, and the even

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2015-12-18 15:15:47